ABSTRACT-The effects of disulfiram (DS) and its major metabolite, diethyldithiocarbamate (DEDC), on the survival time under normobaric and hypobaric hypoxia were examined in mice. At an ambient temperature of 241C, DS at 0.5 3.0 mmol/kg (i.p.) caused a marked dose-dependent prolongation of the survival time in mice subjected to both types of hypoxia. DEDC also prolonged the survival time, but the effect was less at its higher doses which decreased brain superoxide dismutase. The maximum effects of DS and DEDC were found at 3 hr and 1 hr after injection, respectively. Of the metabolites of DEDC, the cop per complex with DEDC caused a significant effect, whereas neither diethylamine nor carbon disulfide did. Furthermore, DS, DEDC and copper complex caused marked hypothermia, and the time course changes of hypothermia by DS and DEDC closely paralleled those of the degree of anti-hypoxic effects, respectively. At an ambient temperature of 361C, in which the body temperature was maintained near the normal level, both DS and DEDC still exhibited a weak anti-hypoxic effect. These results suggest that DEDC itself, formed as a metabolite of DS, and partly the copper complex produced the anti-hypoxic effect, which could not be ex plained by concomitant hypothermia alone.
The disulfide disulfiram (DS) is rapidly converted in vivo into two molecules of diethyldithiocarbamate (DEDC), its corresponding thiol, which is subsequently further biotransformed (1) (2) (3) (4) . The former compound is in current usage in alcohol aversion therapy, and the lat ter compound is a potent chelator of copper and can in hibit various copper-containing enzymes such as superox ide dismutase (SOD) both in vitro and in vivo (5) . DEDC is well known to exhibit a protective effect against liver in jury induced by various hepatotoxins, and its effect was as sumed to be based on inhibition of the mixed-function ox idase system, which activated the hepatotoxins to toxic metabolites (6 8) . Furthermore, there were many reports dealing with the influence of DS and DEDC on oxygen toxicity in lungs and brain, although the results were different among investigators (9) (10) (11) (12) (13) . However, there has been no information on the effects of DEDC and DS on hypoxic injury.
In the present study, we investigated the influences of DEDC and DS on cerebral hypoxic injury using a hypoxic mouse model, in which the survival time was measured in mice exposed to hypoxia.
MATERIALS AND METHODS
Chemicals and animals DS, DEDC, diethylamine and carbon disulfide were obtained from Wako Pure Chemical Industries, Osaka.
(DEDC)2Cu, (DEDC)2Zn and (DEDC)3Fe were from Tokyo Kasei Kogyo Co., Ltd., Tokyo. Other reagents used were of analytical grade. The animals used were male ICR mice weighing about 30 g (5 to 6-week-old) and were obtained from Japan SLC, Inc., Hamamatsu. They were housed on a 12-hr light-dark cycle (light 7:00-19:00 hr) with food and water freely available. The experiments were usually carried out at a constant temperature of 241C. In the experiments evaluating the influence of an ambient temperature, at 90 min before the experiments, mice we introduced into a thermocontrolled room in which the ambient temperature was 361C.
Experimental hypoxia
In the test of normobaric hypoxia, mice were placed in a chamber (plastic desiccator, 2.5 1) through which a gas mixture of nitrogen and oxygen (96:4 v/v) flowed at the rate of 5 1/min. The survival time was determined by the time interval between the start of introduction of mice into the hypoxic gas chamber and the cessation of respira tion.
In the test of hypobaric hypoxia, mice were placed in a chamber (glass desiccator, 12 1), equipped with a vacuum pump and manometer. The inside pressure of the cham ber was lowered to 200 mmHg within 25 sec by initiating air suction. The survival time was determined by the time interval between the start of air suction and the cessation of respiration.
Assay of body temperature
Body temperature was measured with a thermister probe (SK-1250MC; Sato Keiryoki MFG. Co., Ltd., Tokyo), the tip of which was inserted to a depth of 2 cm into the anus of a mouse.
Assay of SOD SOD was measured by the method of Heikkila and Cabbat which is based on the inhibitory action of SOD on the rate of 6-hydroxydopamine auto-oxidation (14) .
Statistical analysis
Data were shown as the mean±S.E.M. Comparisons of the mean values were made by analysis of variance fol lowed by Duncan's multiple range test. 
RESULTS
At an ambient temperature of 241C, the survival time of the control mice averaged about 5 min under the normo baric hypoxic condition. Pretreatment for 0.5 hr with DS (1.00-3.00 mmol/kg, i.p.) markedly and dose-depend ently prolonged the survival time (Table 1) . DEDC (0.25 2.00 mmol/kg) also caused a similar effect, but the effects were diminished in the case of higher doses, and they were completely abolished at a dose of 6.00 mmol/kg.
In hypobaric hypoxia, the survival time of the control mice averaged about 3 min. Under this condition, similar prolongation of the survival time was observed. Figure 1 shows the time course of change of the anti hypoxic effects induced by DEDC and DS. The maximum effect of DEDC was found at 1 hr and disappeared at 3 hr. The effect of DS lasted 3 hr, and its peak was found at 3 hr. DS was reported to be rapidly metabolized to DEDC (1-3). DEDC was known to be metabolized reductively into diethylamine and carbon disulfide (1-3). Further more, there was an another metabolic pathway in which DEDC reacted with metal ions to form a chelate complex with metals, mainly the copper complex (4). Thus, the effects of these metabolites were examined (Table 2) . While neither diethylamine nor carbon disulfide had any anti-hypoxic effect, the copper complex had a marked effect. The zinc complex exhibited a similar complex, but the iron complex had no effect. From the above data, the effect of DS is likely to be developed via metabolic conver sion into DEDC and also partly involves the DEDC-cop per complex, although the anti-hypoxic effect of DS itself could not be excluded.
There have been many reports that the protection from the lethal effects of hypoxia by drugs can be accounted for by drug-induced hypothermia (15 17) . Therefore, we ex amined the effect of the drug on body temperature, which was done by sequential measurement in the same mice over 5 or 6 hr. Both DS and DEDC markedly decreased body temperature (Fig. 2, A and B) . The degree and dura tion of the hypothermia by DEDC were both dose-de pendent, and the hypothermic effect was transient. The peak fall in body temperature occurred 0.5 -1 hr after injection. The degree of the hypothermic effect by DS was smaller during the earlier period, but the duration was longer: the peak fall was at 2-3 hr. The complexes of DEDC with copper and zinc caused dose-dependent hypothermia, and the effects were strengthened with the passing of time (Fig. 2, C and D) . The complex with iron had no effect.
To elucidate the role of hypothermia in the anti-hypox ic effect induced by DS and DEDC, experiments were car ried out at the ambient temperature of 36C, which was high enough to maintain body temperature. Under these conditions, the hypothermic effect of DEDC was abol ished, but that of DS still remained (Fig. 2 , E and F).
As shown in Table 3 , at the ambient temperature of 361C, both DS and DEDC still exhibited a weak anti hypoxic effect. These findings suggest that the anti-hypox ic effect by DS and DEDC could not be explained by the concomitant hypothermia alone.
DEDC is well known to inhibit the copper-zinc form of SOD (5) . In the present study, the small doses (0.50 to 2.00 mmol/kg) of DEDC used did not decrease brain SOD, whereas its high doses markedly decreased the SOD contents. DS did not influence the brain SOD (Table 4 ). Since the brain SOD level was not changed by the doses of DEDC and DS exhibiting the anti-hypoxic activity, the anti-hypoxic effect may have no definite relationship to the brain SOD contents. However, the possibility that the disappearance of the anti-hypoxic effect with the high dose of DEDC (6.00 mmol/kg) may be associated with the marked decrease of brain SOD can not be ruled out. 
DISCUSSION
Both DS and DEDC were found to dose-dependently protect against the lethal effect of hypoxia at the ambient temperature of 241C. Especially, the anti-hypoxic effect of DEDC was seen at the smaller doses. The pretreatment time for the maximal effect was less for DEDC than for DS. While maximal effect was observed when DEDC was injected to mice 1 hr before hypoxia, a 3-hr pretreatment prior to hypoxia was needed for the production of the maximal effect with DS. DS is rapidly converted to DEDC and the latter compound subsequently further metabo lized to diethylamine, carbon disulfide and DEDC-copper complex, etc. (1-4) . The copper complex possessed a remarkable effect, but neither diethylamine nor carbon disulfide did. The zinc complex also exhibited an anti hypoxic effect, but the iron complex did not. These find ings suggest that DEDC and its copper complex among the metabolites from DS may be involved in the DS induced anti-hypoxic effect, although the anti-hypoxic effect of DS itself could not be excluded. Conclusive proof will require the demonstration of the relationship between the anti-hypoxic effects of DS and DEDC and their blood contents and/or the influence of a metabolic inhibitor of DS on the anti-hypoxic effect of DS. Although various copper complexes were reported to possess SOD-like activity (18) , the present copper com plex (10-4 M) had no such activity in vitro (data not shown). Higher doses of DEDC that inactivated SOD did not exhibit an anti-hypoxic effect, but remarkable effects were observed at the smaller doses that did not decrease brain SOD content. There have been numerous reports that DS and DEDC possessed an anti-oxidative effect (9) (10) (11) (19) (20) (21) (22) . Although there is a great difference be tween hypoxia and oxygen-induced tissue injury, the present anti-hypoxic effect was produced in a dose-de pendent manner in the low dose range of DEDC, and the disappearance of the anti-hypoxic effect was observed at its higher doses accompanied with the marked decrease in brain SOD level. Such variation of DEDC effects is likely to relate to either an anti-oxidative activity or an indirect pro-oxidative effect via SOD depletion, depending on the dosage used. However, since it remains to be determined if there is a relationship between the anti-oxidative defense mechanisms and acute lethality by hypoxia, it could not be concluded that the anti-oxidative effect with DEDC and DS is involved in prolonging the survival time of mice exposed to hypoxia. Hypothermia is known to protect animals from hypox ia (15 17) . The protective effects of hypothermia against hypoxia are thought to involve decreases in brain meta bolic rate and increased affinity of hemoglobin for oxygen (23, 24) . Namely, under hypoxic conditions, the levels of 
